Real World Practice
and Pathways to the Future

Click here for the full conference brochure

Keynote Speakers
Monday, June 9, 2014  8:00 a.m.

Opioids for Chronic Pain:  Deconstructing the Evidence
Russell Portenoy, MD

     Dr. Russell Portenoy is chairman of the Department of Pain Medicine and Palliative Care and the Gerald J. Friedman Chair in Pain Medicine and Palliative Care at Beth Israel Medical Center, New York. He is the Chief Medical Officer of MJHS Hospice and Palliative Care and Professor of Neurology and Anesthesiology at the Albert Einstein College of Medicine.

     Dr. Portenoy is past-president of the American Academy of Hospice and Palliative Medicine and past-president of the American Pain Society. He previously chaired the American Board of Hospice and Palliative Medicine and served on the Council of the International Association for the Study of Pain. He is a recipient of the Lifetime Achievement Award and the National Leadership Award of the American Academy of Hospice and Palliative Medicine, has received both the Wilbert Fordyce Award for Lifetime Excellence in Clinical Investigation and the Distinguished Service Award from the American Pain Society, and was given the Founder’s Award by the American Academy of Pain Medicine.

     Dr. Portenoy has been Editor-in-Chief of the Journal of Pain and Symptom Management for more than two decades, coedits the Oxford Textbook of Palliative Medicine, and is editor for the palliative care section of The Oncologist. He serves on numerous other editorial boards. He has written, co-authored, or edited 21 books and more than 525 papers and book chapters on topics in pain and symptom management, opioid pharmacotherapy and palliative care.

Monday, June 9, 2014 1:30 p.m.

Opioid Prescribing: SAMHSA's Approach to Helping
Clinicians with What They Need to Know

Elinore McCance-Katz, MD

     Dr. Elinore McCance-Katz is the first chief medical officer appointed at the Substance Abuse and Mental Health Services Administration (SAMHSA). Previously at the University of California San Francisco, Dr. McCance-Katz was a Professor of Psychiatry, and was the State Medical Director for the California Department of Alcohol and Drug Programs. She is board-certified in General Psychiatry and Addiction Psychiatry and is a Distinguished Fellow of the American Academy of Addiction Psychiatry. Dr. McCance-Katz has been working in the field of addiction medicine for 22 years as a clinician, teacher and clinical researcher. Her specialty areas include pharmacotherapy for substance use disorders, clinical pharmacology of drugs of abuse, drug interactions, cocaine/alcohol/opioid medications development, and co-occurring HIV disease and addiction. Her clinical interests are in the treatment of those with co-occurring substance use disorders, infectious diseases including HIV and HCV and mental illness. She is also interested in the treatment of those with chronic pain who have developed problems with opioid analgesic overuse/misuse often with co-occurring mental illness.

     Prior to her appointment, Dr. McCance-Katz was the Medical Director of the Physicians’ Clinical Support System for Buprenorphine and the Prescribers’ Clinical Support System for Opioid Therapies which are Center for Substance Abuse Treatment (CSAT)/SAMHSA-sponsored national training and peer support programs for physicians and clinicians treating patients with clinical need for opioid medications. She has also helped to develop educational curricula to assist with the integration of substance use screening, brief intervention and treatment referral into primary care settings through an SBIRT grant to UCSF.

     Internationally, Dr. McCance-Katz has been part of a World Health Organization (WHO) committee to develop guidelines on the treatment of drug users living with HIV/AIDS and has reviewed and contributed to WHO white papers on methadone and buprenorphine treatment of opiate addiction. She participated in the President’s Emergency Program for AIDS Relief(PEPFAR) where she  assisted with the development of methadone maintenance programs in Vietnam. Most recently, Dr. McCance-Katz has conducted studies of drug-drug interactions between opioids or alcohol and HIV therapeutics through research studies funded by NIAAA/NIH and drug interactions between disulfiram and HIV therapeutics funded by NIDA/NIH.

Sunday, June 8, 2014  10:30 a.m.

The process and some outcomes of "institutionalizing" pain care within the primary care network covered by IHC.
Wayne H. Cannon, MD

     Dr. Cannon attended medical school at the University of Utah and his Residency in pediatrics at the University of Utah/Primary Children’s Medical Center. He is the Medical Director for the Primary Care Clinical Program at Intermountain Healthcare where he oversees the development, implementation and coordination of system wide primary care initiatives at Intermountain. Dr. Cannon chaired the development of Intermountain’s Chronic Pain Care Process Model for primary care physicians when it was developed in 2010. Dr. Cannon is a Board Certified pediatrician.

Condensed Schedule - Updated June 6, 2014

Please note Registration is open from 12 p.m. to 4 p.m. on Saturday June 7, 2014.
Grab your badge and avoid the lines when the conference opens on Sunday morning.

Sunday, June 8, 2014

7:00 a.m.  
Light Breakfast 
Registration Open

8:45 a.m.
Chairman's Welcome
Paul Sloan, MD
Perry Fine, MD

9:00 a.m.
Rational Prescribing: Customized Solutions
for Medication Management
in an Integrated Practice

David DiBenedetto, MD
Zahid Bajwa, MD
Daniel Carr, MD
Rachel Porter, RN

10:00 a.m.

10:30 a.m.
Keynote Address
The process and some outcomes
of "institutionalizing" pain care within
the primary care network covered by IHC.

Wayne H. Cannon, MD

11:30 a.m.
Federation of State Medical Boards Policy
on Use of Opioid 
Real Life Application

Dr. Grider, KY Medical Board

12:30 p.m.

1:30 p.m.
Buprenorphine: an Upfront Analgesic
for Pain Management

Mellar Davis, MD

2:15 p.m.
Clinical guidelines on the application of buprenorphine in the treatment of painful neuropathies and pain syndromes in special patient populations.
Guy Hans, MD, PhD

3:00 p.m.
 Postmortem Redistribution (PMR)
and its Impact on Determining Prescriber Liability in Civil and Criminal Legal Cases.

David M. Benjamin, PhD

3:30 p.m.

4:00 p.m.
Opiate Abuse and Addiction
in the Competitive Athlete

Tad Seifert, MD

4:20 p.m.
 Disciplinary Proceedings  for Abuse of Opioid Medications by Physicians in Australia
 Danuta Mendelson, MD
George Mendelson, MD

 4:40 p.m.
Opioid Abuse
Among Sickle Cell Disease Patients
In Nigeria

Taiwo Kotila, MD
Oluwasogo Busari, MD
Olayinka Eyelade, MBBS, MSc, FWACS

5:00 p.m.
Opioid Error in Paediatric Hospital Practice
Conor Mc Donnell, MD
  Renu Roy, BSP, RPh 
Jason Maynes, MD
Daniel Stocki, MD

5:30 p.m. End of Day 1

Monday, June 9, 2014

7:00 a.m.
Light Breakfast
Registration Open

8:00 a.m.
Keynote Address
Opioids for Chronic Pain:
 Deconstructing the Evidence

Russell Portenoy, MD

8:45 a.m.
Opioid Rotation
Lynn Webster, MD
Mary Lynn McPherson, PharmD
Russell Portenoy, MD

10:15 a.m. Break-EXHIBITS OPEN

10:45 a.m.
The Multidimensional Nature of Pain:
Implications for Management

Seddon Savage, MD

11:15 a.m.
UDT in Opioid Therapies
Gary Reisfield, MD

11:45 a.m.
Opioids analgesia and hyperalgesia
Elon Eisenberg, MD
Dorit Pud, PhD 
Jianren Mao, MD, PhD

12:30 p.m. Lunch-EXHIBITS OPEN

1:30 p.m. 
Plenary Session
Opioid Prescribing:
SAMHSA's Approach to Helping
Clinicians with What They Need to Know

Elinore McCance-Katz, MD

2:15 p.m.
Basic Clinical Opioid Pharmacology
Gav Pasternak, MD

3:00 p.m.
Abuse Deterrant Formulations
Lynn Webster, MD
Mary Lynn McPherson, PharmD

3:30 p.m.

4:00 p.m.
Colliding Consequences
 of Opioid Prescribing:
Which Ethical Principles Prevail?

Larry C. Driver, MD
Michael C. Schatman, PhD

4:45 p.m.
Opioid Case Studies
Carol Warfield, MD

5:30 p.m. End of Day 2

Tuesday, June 10, 2014

7:00 a.m.
Light Breakfast
Registration Open

8:00 a.m.
Keynote Address
 Essential Legal Issues Associated with
In-Office Toxicology Laboratories and Physician Third-Party Relationships
with Laboratory Consultants
 and Independent Clinical Laboratories

Jennifer Bolen, JD
Jane Pine Wood, JD
Richard Cooper, JD
Christy Petru

9:15 a.m.
Ongoing work within
Department of Defense/VAMC

Rollin "Mac" Gallagher, MD, MPH

10:15 a.m.

10:45 a.m.
Investigation of Genetic Variations
 in Mesolimbic Dopamine System
and Elevated Risk of Opioid Abuse
 in Chronic Pain Patients

Bilikis Akindele, MD
Derrick Holman
Brian Meshkin
Tobore Onojighofia
Daniel Schwarz, MD, Presenting

11:30 a.m.
Project Lazarus
 and the Chronic Pain Initiative:
A Retrospective Review
 of a Successful Community-Based
 Overdose Prevention Initiative

David Marks, MD
James Finch, MD
12:00 p.m.
Medical Cannabinoids:
What every medical professional
should know about the
endocannabinoid system
and pain management.
How to handle questions from your patients.

Gil Fanciullo, MD
Perry Fine, MD

1:00 p.m.
Adjourn ICOO 2014

1:00 p.m. - 3:00 p.m.
I.A.P.C.D. Annual Meeting
Luncheon Presentation
Opioid Inaccessibility in Low Resource Countries and the Unnecessary Suffering
of the Global Poor:
Legal, Ethical and Social Issues

S. Asra Husain, JD, MA
Diederik Lohman
Eric Krakauer MD
Shalini Vallabhan, MD

Please bookmark this page and check back periodically.
Schedule Subject to change without notice